Harish Pulluru

Epidemiology and Risk Factors for Isolation of Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamase in a Large U.S. Medical Center

Kayoko Hayakawa, Sureka Gattu, Dror Marchaim et al. · Antimicrobial Agents and Chemotherapy · 2013 · 71 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Comparison of the Clinical Characteristics and Outcomes Associated with Vancomycin-Resistant Enterococcus faecalis and Vancomycin-Resistant E. faecium Bacteremia

Kayoko Hayakawa, Dror Marchaim, Emily T. Martin et al. · Antimicrobial Agents and Chemotherapy · 2012 · 53 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Treatment of Methicillin-Resistant Staphylococcus aureus Infections with a Minimal Inhibitory Concentration of 2 μg/mL to Vancomycin: Old (Trimethoprim/Sulfamethoxazole) versus New (Daptomycin or Linezolid) Agents

Michelle Campbell, Dror Marchaim, Jason M. Pogue et al. · Annals of Pharmacotherapy · 2012 · 46 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Epidemiology of Vancomycin-Resistant Enterococcus faecalis: a Case-Case-Control Study

Kayoko Hayakawa, Dror Marchaim, Mohan Palla et al. · Antimicrobial Agents and Chemotherapy · 2012 · 44 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Comparative outcomes of combined corticosteroid and remdesivir therapy with corticosteroid monotherapy in ventilated COVID-19 patients

Subhadra Mandadi, Harish Pulluru, Frank Annie · PLoS ONE · 2022 · 13 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17